Comments

Response to Comment on: “Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasiarelated changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin”

Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam
Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam
Haematologica Early view Aug 27, 2026 https://doi.org/10.3324/haematol.2026.301796